MONICA WHITE: Open Payments
NPI 1235145558 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,274 in 31 payments from 17 companies in 2025. Trend: 2023 $3,877 · 2024 $1,361 · 2025 $2,274
Consulting: $1,200Food & beverage: $780Travel & lodging: $294
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $1,534 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $165 |
| PFIZER INC. | 4 | $87 |
| Myriad Genetic Laboratories, Inc. | 2 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: DATROWAY, FRUZAQLA, MYRISK, LIBTAYO, EPKINLY, OPDIVO, ENHERTU, KISQALI.
Industry payments across TX — which companies pay providers there.
